JNJ vs LEA · P/E 17, rev $49.37B vs P/E 14, rev $12.03B
Johnson & Johnson (JNJ) versus Lear Corporation (LEA) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Lear Corporation (LEA) is a auto parts company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported LEA revenue for 2026-07-04 was $12.03B. Net income was $365.1M. LEA currently screens at market cap $7.21B and trailing P/E 14.4.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. LEA currently screens at market cap $7.21B and trailing P/E 14.4.
Not investment advice. Open the JNJ and LEA stock pages for the full models.
Not investment advice.